Want to join the conversation?
Jason Mills of Canaccord asks about the market dynamics with respect to AngioVac. $ANGO CEO Jim Clemmer replied that there is not really a competitive offering from a product standpoint that can do what this product does. He added that the challenge for the company is just making sure it is going to market in a proper way.
$DB is going to cut off services for about 3,400 clients in equities trading.
$F stock slid more than 2% after the company issued two safety recalls involving more than 650,000 Ford Fusion and Lincoln MKZ model cars.
The new CEO of $SBUX, Kevin Johnson, has some pretty large shoes to fill but there are many who have good faith in his ability to do so.
$TSLA opening a showroom in Michigan. A bold move !!